MONETA GROUP INVESTMENT ADVISORS LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1120927 ST LOUIS, MO

Position in VRTX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$444,753

-$57,116 QoQ

Shares Held

996

-10.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MONETA GROUP INVESTMENT ADVISORS LLC holds $1,862,709 across 8 Biotechnology names. VRTX ranks #1 (23.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	996	$444,753
2	ONC	BeOne Medicines Ltd.	1,307	$388,139
3	REGN	Regeneron Pharmaceuticals, Inc.	478	$369,321
4	CAPR	Capricor Therapeutics, Inc.	9,399	$285,729
5	CADL	Candel Therapeutics, Inc.	41,867	$205,148
6	ABUS	Arbutus Biopharma Corp	26,000	$117,000
7	ALXO	Alx Oncology Holdings Inc	15,196	$30,467
8	LGVN	Longeveron Inc.	21,300	$22,152

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$444,753	996	-10.0%	Shares	Sole	2026-05-12
2025-12-31	$501,869	1,107	-5.9%	Shares	Sole	2026-02-12
2025-09-30	$460,960	1,177	-5.5%	Shares	Sole	2025-11-14
2025-06-30	$554,719	1,246	+6.3%	Shares	Sole	2025-08-14
2025-03-31	$568,209	1,172	+10.6%	Shares	Sole	2025-05-15
2024-12-31	$426,862	1,060	-18.8%	Shares	Sole	2025-02-11
2024-09-30	$607,394	1,306	+3.9%	Shares	Sole	2024-11-12
2024-06-30	$589,181	1,257	-5.9%	Shares	Sole	2024-08-13
2024-03-31	$558,461	1,336	+40.8%	Shares	Sole	2024-08-13
2023-12-31	$386,138	949	+7.2%	Shares	Sole	2024-02-15
2023-09-30	$307,749	885	-10.7%	Shares	Sole	2023-11-15
2023-06-30	$348,742	991	+20.4%	Shares	Sole	2023-08-15
2023-03-31	$259,302	823	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.